- Home
- KROS vs TRST Comparison
KROS vs TRST Comparison
Compare KROS & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- TRST
- Stock Information
- Founded
- KROS 2015
- TRST 1902
- Country
- KROS United States
- TRST United States
- Employees
- KROS N/A
- TRST N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- TRST Major Banks
- Sector
- KROS Health Care
- TRST Finance
- Exchange
- KROS Nasdaq
- TRST Nasdaq
- Market Cap
- KROS 589.8M
- TRST 642.6M
- IPO Year
- KROS 2020
- TRST N/A
- Fundamental
- Price
- KROS $10.15
- TRST $32.31
- Analyst Decision
- KROS Buy
- TRST
- Analyst Count
- KROS 11
- TRST 0
- Target Price
- KROS $68.83
- TRST N/A
- AVG Volume (30 Days)
- KROS 1.9M
- TRST 121.7K
- Earning Date
- KROS 02-26-2025
- TRST 01-21-2025
- Dividend Yield
- KROS N/A
- TRST 4.44%
- EPS Growth
- KROS N/A
- TRST N/A
- EPS
- KROS N/A
- TRST 2.48
- Revenue
- KROS $651,000.00
- TRST $168,593,000.00
- Revenue This Year
- KROS $303.39
- TRST N/A
- Revenue Next Year
- KROS N/A
- TRST $11.69
- P/E Ratio
- KROS N/A
- TRST $12.82
- Revenue Growth
- KROS 8037.50
- TRST N/A
- 52 Week Low
- KROS $9.78
- TRST $25.83
- 52 Week High
- KROS $73.00
- TRST $38.89
- Technical
- Relative Strength Index (RSI)
- KROS 18.48
- TRST 40.76
- Support Level
- KROS $9.78
- TRST $30.15
- Resistance Level
- KROS $16.49
- TRST $32.94
- Average True Range (ATR)
- KROS 0.89
- TRST 0.83
- MACD
- KROS 0.91
- TRST -0.00
- Stochastic Oscillator
- KROS 7.36
- TRST 53.84
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.